PEA for nerve and inflammatory pain: the body’s own painkiller in supplement form

PEA for nerve and inflammatory pain: the body's own painkiller, in supplement form

A fatty acid your body already makes to calm pain and neuroinflammation, with strong trial evidence and an almost clean safety record.

A fatty acid your body already makes to calm pain and neuroinflammation, with strong trial evidence and an almost clean safety record.

Time to effect

4–8 weeks

4–8 weeks

Dose

600mg twice daily (1,200mg/day) for at least 4–8 weeks

600mg twice daily (1,200mg/day) for at least 4–8 weeks

Active compound

Micronized or ultra-micronized PEA

Micronized or ultra-micronized PEA

▪ The challenge at hand

Chronic nerve-related and inflammatory pain, the burning, aching, persistent kind seen in diabetic neuropathy, sciatica, and fibromyalgia, is notoriously hard to treat. Conventional painkillers often help little, and the drugs that do (gabapentinoids, opioids) carry sedation, dependence, and other burdens that make long-term use difficult.

Palmitoylethanolamide (PEA) is an unusual option because your body already makes it to dampen its own pain and neuroinflammation. Despite a 2023 meta-analysis of eleven controlled trials showing a large effect with essentially no serious side effects, it's almost absent from Western pain practice. The catch is form: standard PEA is poorly absorbed, so the micronized version is what actually reaches therapeutic levels.

▪ What it is

Palmitoylethanolamide (PEA) is a fatty-acid compound the body produces naturally to regulate pain and inflammation, taken as a daily supplement in a micronized form for absorption.

Why this is surprising

PEA is a fatty-acid amide the body produces itself to turn down pain and neuroinflammation, yet it's nearly unknown in Western pain care despite a 2023 meta-analysis of 11 double-blind RCTs (774 patients) showing a large effect with no significant adverse events. It isn't a conventional painkiller; it raises the threshold at which pain signaling and neuroinflammation amplify. And the micronization requirement rules out most products on the shelf.

▪ How it works

Turning down the body’s pain amplifier.

PEA acts mainly as a PPAR-alpha agonist and works through an 'entourage effect,' boosting the body's own endocannabinoid (anandamide) tone and calming the mast cells and microglia that drive neuroinflammation. That dampens the inflammatory amplification which converts acute pain into chronic pain. Because PEA dissolves poorly in water, a micronized or ultra-micronized particle size is required to reach effective blood levels.

▪ The research

What the evidence says

A 2023 systematic review and meta-analysis of 11 double-blind randomized controlled trials (774 patients) found that PEA produced a large reduction in chronic pain compared with control, with no significant adverse events reported across the pooled data. The consistency across trials is notable; the moderate rating reflects variation in pain types studied and formulations used.

Lang-Illievich K et al. Nutrients. 2023;15(6):1350. PMID: 36986080.

WE'VE COACHED THOUSANDS OF USERS WITH THEIR PAIN

WE'VE COACHED THOUSANDS OF USERS WITH THEIR PAIN

PEA for nerve and inflammatory pain, in practice

PEA for nerve and inflammatory pain, in practice

PEA for nerve and inflammatory pain, in practice

Pain management is deeply personal, and response rates reflect real variability between individuals. Here's how it played out for people actually tracking it.

Pain management is deeply personal, and response rates reflect real variability between individuals. Here's how it played out for people actually tracking it.

Pain management is deeply personal, and response rates reflect real variability between individuals. Here's how it played out for people actually tracking it.

381

381

started

82%

82%

completed

53%

53%

noticed a change

25%

25%

made it routine

Self-reported by Coco users. Not a clinical outcome.

Self-reported by Coco users. Not a clinical outcome.

Data across the Coco Health user base, not a clinical outcome.

▪ What to look for

A practical buying guide

The single most important label detail is 'micronized' or 'ultra-micronized.' Standard (non-micronized) PEA is poorly absorbed and is what most shelf products contain, which is likely why people try PEA and feel nothing. Look specifically for a micronized form, and give it the full 4–8 weeks; it builds gradually rather than working acutely.

Coco is the AI health coach that runs experiments like this one with you

Know exactly what to do: Coco sets the protocol and checks in by call or message

See what's actually changing: Coco tracks your symptoms and synthesizes the trend

Get a real answer: Coco tells you whether the data supports continuing or stopping

▪ What to expect over time

PEA is not an acute painkiller. In the trials, benefits built over 4–8 weeks of consistent daily use, so it's worth committing to that window before judging.

Side effects

Exceptionally well tolerated across trials. Occasional mild GI upset. No significant adverse events emerged in the pooled trial data. Always consult a care provider when adding or removing a supplement.

Who should be cautious

Insufficient data in pregnancy and lactation. Theoretical additive effect with other endocannabinoid-modulating agents. This is not an acute rescue painkiller; it requires 4–8 weeks of consistent use to judge.

FAQ

How is this different from a normal painkiller?

Why does 'micronized' matter so much?

Is Coco a replacement for my doctor?

Coco helps you turn health ideas like this into small, trackable experiments you can actually stick with.

The hard part isn't starting — it's knowing if it's working

Stay consistent: Coco checks in so you don't have to rely on motivation

See clearly: Coco reads your symptom data so you can trust what you're seeing

Get a real answer: Coco tells you whether it's working, even if it isn't

Educational only. This is not medical advice. Always talk with a qualified clinician before changing medications, supplements, or care plans.